Molecular Templates, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components (Tables)

Balance Sheet Components (Tables)

3 Months Ended

Mar. 31, 2018

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Components of Accrued Liabilities

Accrued liabilities were comprised of the following (in thousands):

		March 31,				December 31,
		2018				2017
Accrued liabilities:
General and administrative		$	670			$	374
Clinical costs			734				702
Non-clinical research			868				435
Payroll related			491				1,149
Other accrued expenses			37				30
Total accrued liabilities		$	2,800			$	2,690

Components of Deferred Revenue

Deferred revenue was comprised of the following:

		March 31,				December 31,
		2018				2017
Deferred revenue:
Grant agreements		$	1,421			$	1,673
Research and development agreements			4,929				1,092
Total deferred revenue		$	6,350			$	2,765